Country: European Union
Language: English
Source: EMA (European Medicines Agency)
dibotermin alfa
Medtronic BioPharma B.V.
M05BC01
dibotermin alfa
Drugs for treatment of bone diseases
Tibial Fractures; Fracture Fixation, Internal; Spinal Fusion
Inductos is indicated for single level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non operative treatment for this condition.Inductos is indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation.
Revision: 23
Authorised
2002-09-09
40 B. PACKAGE LEAFLET 41 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT INDUCTOS 1.5 MG/ML POWDER, SOLVENT AND MATRIX FOR IMPLANTATION MATRIX dibotermin alfa READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor. − If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What InductOs is and what it is used for 2. What you need to know before you receive InductOs 3. How InductOs is given 4. Possible side effects 5. How to store InductOs 6. Contents of the pack and other information 1. WHAT INDUCTOS IS AND WHAT IT IS USED FOR InductOs contains the active substance, dibotermin alfa. It is a copy of a protein called bone morphogenetic protein 2 (BMP-2), which is produced naturally by the body and helps with the formation of new bone tissue. InductOs may be used either in lower back spine fusion surgery or to repair fractures of the shin bone. _ _ _Lower back spine fusion surgery_ If you have a lot of pain from a damaged disc in your lower back, and other treatments have not proven effective, you may be considered for lower back spine fusion surgery. InductOs is used instead of taking a bone graft from your hip; this avoids the problems and pain that can be caused by an operation to collect the bone graft. When used in lower back fusion surgery, InductOs is used in combination with a medical device, which corrects the position of your spine. If you have any question about the medical device, please ask your doctor. _Fractures of the shin bone_ If you have broken your shin bone, InductOs is used, to help your fracture heal and to reduce the need for additional surgeries. It is used in addition to standard treatment and care of shin bone fractures. 2. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE INDUCTOS YOU SHOULD NOT RECEIVE INDUCTOS • if you a Read the complete document
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1 NAME OF THE MEDICINAL PRODUCT InductOs 1.5 mg/ml powder, solvent and matrix for implantation matrix 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One vial contains 4 mg (4 mg pack) or 12 mg (12 mg pack) dibotermin alfa. After reconstitution, InductOs contains 1.5 mg/ml dibotermin alfa. Dibotermin alfa (recombinant human Bone Morphogenetic Protein-2; rhBMP-2) is a human protein derived from a recombinant Chinese Hamster Ovary (CHO) cell line. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder, solvent and matrix for implantation matrix. The powder is white. The solvent is a clear colourless liquid. The matrix is white. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS InductOs is indicated for single-level lumbar interbody spine fusion as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least 6 months of non-operative treatment for this condition. _ _ InductOs is indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation. See section 5.1. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION InductOs should be used by an appropriately qualified surgeon. Posology InductOs must be prepared exactly in accordance with the directions for preparation (see section 6.6). The appropriate dose is determined by the volume of wetted matrix required for the intended indication. If the surgical setting requires that only a portion of the product is needed, the wetted matrix should be cut to the desired size, and the unused portion must be discarded. 3 _Dosing table for InductOs 4 mg pack _ INDUCTOS WETTED MATRICES (4 MG PACK) DIMENSIONS OF WETTED MATRIX VOLUME OF WETTED MATRIX CONCENTRATION OF WETTED MATRIX DIBOTERMIN ALFA DOSE 1 matrix 2.5 cm x 5 cm 1.3 cm 3 1.5 mg/cm 3 2 mg 2 matrices 2 x (2.5 cm x 5 cm) 2.7 cm 3 1.5 mg/cm 3 4 mg _ _ _Dosing table for InductOs 12 mg pack _ PORTION OF INDUCTOS WETTED MATRIX (12 M Read the complete document